Ozkan Alan
Marmara University
44 Papers
36 Citations
Ozkan Alan is an academic researcher from Marmara University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 31 publications.
Chat about Author
Papers
Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment
Ozkan Alan,Tugba Akin Telli,Bilge Aktas,Sinan Koca,Ilker Nihat Okten,Rahib Hasanov,Tugba Basoglu,Rukiye Arikan,Nazım Can Demircan,Ozlem Ercelep,Serap Kaya,Mustafa Umit Ugurlu,Handan Kaya,Nalan Akgul Babacan,Faysal Dane,Perran Fulden Yumuk +15 more
TL;DR: It is revealed that insulin resistance may have a negative effect on pathological complete response (pCR) following neoadjuvant therapy particularly with hormone-positive and Her-2-negative cases of non-diabetic breast cancer.
Chordoma: a case series and review of the literature
Ozkan Alan,Tugba Akin Telli,Ozlem Ercelep,Eda Tanrikulu Simsek,Tugba Basoglu Tuylu,Aydan Mutis,Rahib Hasanov,Serap Kaya,Nalan Akgul Babacan,Faysal Dane,Perran Fulden Yumuk +10 more
TL;DR: Chordoma has few systemic treatment options and they have limited benefit, so Randomized trials with large patient numbers are unfeasible in this rare disease and new treatment strategies are needed.
Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma
Ozlem Ercelep,Ozkan Alan,Tugba Akin Telli,Tugba Basoglu Tuylu,Rukiye Arikan,Nazım Can Demircan,Eda Tanrikulu Simsek,Nalan Akgul Babacan,Serap Kaya,Faysal Dane,Emine Bozkurtlar,Tunc Ones,Tunc Lacin,Perran Fulden Yumuk +13 more
TL;DR: Different SUVmax values are seen in different histologic subtypes of nonmetastatic lung adenocarcinoma, which consists of a diverse group of diseases.
14
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience
Aykut Bahceci,Semra Paydas,Naziye Ak,Ferhat Ferhatoglu,Pinar Saip,Gulsah Seydaoglu,Mehmet Bilici,Melih Simsek,Salim Basol Tekin,Zuleyha Calikusu,Sinan Yavuz,Ahmet Z. Sahin,Erdem Cubukcu,Turkkan Evrensel,Serkan Degirmencioglu,Atike Gökçen Demiray,Perran Fulden Yumuk,Ozkan Alan,Duygu Ilke Cikman,Fuat Demirelli,Osman Kostek,Ali Gökyer,Mutlu Dogan,Oznur Bal,Burcu Çakar,Erhan Gokmen,Deniz Yamac,Taner Korkmaz,Altay Aliyev,Özge Keskin,Semiha Urvay,Mahmut Büyükşimşek,Cemile Karadeniz,Birol Yildiz,Havva Yesil Cinkir,Hacer Demir,Ismail Beypinar,Cengiz Karacin,Kadir Eser,Meltem Baykara,Saadettin Kilickap,Kerem Okutur,Gulcan Bulut,Ali Alkan,Erkan Arpaci,Kezban Nur Pilanci,Atakan Demir,Deniz Işik,Nilgün Yildirim +48 more
TL;DR: In this article, the authors evaluated the efficacy and toxicity of trastuzumab emtansine (T-DM1) in cases with metastatic breast cancer (mBC) in different lines of treatment.
10
A rare case of primary rectal choriocarcinoma and review of the literature
Tugba Akin Telli,Nazım Can Demircan,Ozkan Alan,Tugba Basoglu Tuylu,Rukiye Arikan,Ozlem Ercelep,Ali Emre Atici,Rabia Ergelen,Ipek Erbarut Seven,Nalan Akgul Babacan,Serap Kaya,Faysal Dane,Perran Fulden Yumuk +12 more
TL;DR: This is an extremely rare case of primary rectal choriocarcinoma with a good response to chemotherapy and it seems very important to start prompt treatment to improve patient’s survival.
9